Bright light treatment in elderly patients with Nonseasonal Major Depressive Disorder: A randomized placebo-controlled trial

被引：0
|
作者：
Lieverse, Ritsaert [1 ]
机构：
[1] Amacura, Geleen, Netherlands
来源：
INTERNATIONAL PSYCHOGERIATRICS | 2011年 / 23卷
关键词：
D O I：
暂无
中图分类号：
B849 [应用心理学];
学科分类号：
040203 ;
摘要：
引用
收藏
页码：S19 / S19
页数：1
相关论文
共 50 条
  • [1] Bright Light Treatment in Elderly Patients With Nonseasonal Major Depressive Disorder A Randomized Placebo-Controlled Trial
    Lieverse, Ritsaert
    van Someren, Eus J. W.
    Nielen, Marjan M. A.
    Uitdehaag, Bernard M. J.
    Smit, Jan H.
    Hoogendijk, Witte J. G.
    ARCHIVES OF GENERAL PSYCHIATRY, 2011, 68 (01) : 61 - 70
  • [2] Efficacy of Bright Light Treatment, Fluoxetine, and the Combination in Patients With Nonseasonal Major Depressive Disorder A Randomized Clinical Trial
    Lam, Raymond W.
    Levitt, Anthony J.
    Levitan, Robert D.
    Michalak, Erin E.
    Cheung, Amy H.
    Morehouse, Rachel
    Ramasubbu, Rajamannar
    Yatham, Lakshmi N.
    Tam, Edwin M.
    JAMA PSYCHIATRY, 2016, 73 (01) : 56 - 63
  • [3] CONTROLLED TRIAL OF BRIGHT LIGHT FOR NONSEASONAL MAJOR DEPRESSIVE-DISORDERS
    KRIPKE, DF
    MULLANEY, DJ
    KLAUBER, MR
    RISCH, SC
    GILLIN, JC
    BIOLOGICAL PSYCHIATRY, 1992, 31 (02) : 119 - 134
  • [4] Randomized, placebo-controlled trial of desvenlafaxine succinate in the treatment of major depressive disorder
    DeMartinis, N.
    Yeung, P. P.
    Entsuah, R.
    Manley, A. L.
    INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY, 2006, 9 : S233 - S234
  • [5] Quality of life impacts of bright light treatment, fluoxetine, and the combination in patients with nonseasonal major depressive disorder: A randomized clinical trial
    Morton, Emma
    Michalak, Erin
    Levitt, Anthony
    Levitan, Robert
    Cheung, Amy
    Morehouse, Rachel
    Ramasubbu, Rajamannar
    Yatham, Lakshmi
    Tam, Edwin
    Lam, Raymond
    BIPOLAR DISORDERS, 2020, 22 : 88 - 89
  • [6] Quality of Life Impacts of Bright Light Treatment, Fluoxetine, and the Combination in Patients with Nonseasonal Major Depressive Disorder: A Randomized Clinical Trial
    Morton, Emma
    Michalak, Erin E.
    Levitt, Anthony
    Levitan, Robert D.
    Cheung, Amy
    Morehouse, Rachel
    Ramasubbu, Rajamannar
    Yatham, Lakshmi N.
    Tam, Edwin M.
    Lam, Raymond W.
    CANADIAN JOURNAL OF PSYCHIATRY-REVUE CANADIENNE DE PSYCHIATRIE, 2021, 66 (03): : 289 - 297
  • [7] Placebo-controlled trial of agomelatine in the treatment of major depressive disorder
    Kennedy, SH
    Emsley, R
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2006, 16 (02) : 93 - 100
  • [8] A placebo-controlled trial of escitalopram and sertraline in the treatment of major depressive disorder
    Alexopoulos, GS
    Gordon, J
    Zhang, DZ
    NEUROPSYCHOPHARMACOLOGY, 2004, 29 : S87 - S87
  • [9] A Randomized, Placebo-Controlled Adjunctive Trial of Riluzole in Treatment-Resistant Major Depressive Disorder
    Mathew, Sanjay
    Fava, Maurizio
    Guerguieva, Ralitza
    Sanacora, Gerard
    NEUROPSYCHOPHARMACOLOGY, 2015, 40 : S161 - S162
  • [10] Zuranolone for the Treatment of Adults With Major Depressive Disorder: A Randomized, Placebo-Controlled Phase 3 Trial
    Clayton, Anita H.
    Lasser, Robert
    Parikh, Sagar, V
    Iosifescu, Dan, V
    Jung, Jungah
    Kotecha, Mona
    Forrestal, Fiona
    Jonas, Jeffrey
    Kanes, Stephen J.
    Doherty, James
    AMERICAN JOURNAL OF PSYCHIATRY, 2023, 180 (09): : 676 - 684
12345